应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
CERO CERo Therapeutics Holdings, Inc.
交易中 01-13 13:17:00 EST 延时
资讯
新帖
简况
Cero Therapeutics发布Cer-1236治疗AML的I期临床试验（CERTAINT-1）最新临床进展，重点披露关键安全性数据及骨髓增生异常综合征/AML患者实现无血小板输注间隔
美股速递 · 01-07
Cero Therapeutics发布Cer-1236治疗AML的I期临床试验（CERTAINT-1）最新临床进展，重点披露关键安全性数据及骨髓增生异常综合征/AML患者实现无血小板输注间隔
CERo Therapeutics Holdings, Inc.推进Cer-1236治疗AML的1期临床试验，初始剂量队列中第三名患者开始用药
美股速递 · 2025-09-22
CERo Therapeutics Holdings, Inc.推进Cer-1236治疗AML的1期临床试验，初始剂量队列中第三名患者开始用药
CERo Therapeutics宣布在急性髓系白血病Cer-1236一期研究中进行剂量强化
美股速递 · 2025-09-08
CERo Therapeutics宣布在急性髓系白血病Cer-1236一期研究中进行剂量强化
Cero Therapeutics Holdings, Inc.7月15日成交额为36.71万美元
市场透视 · 2025-07-16
Cero Therapeutics Holdings, Inc.7月15日成交额为36.71万美元
Cero Therapeutics Holdings, Inc.7月14日成交额为52.06万美元
市场透视 · 2025-07-15
Cero Therapeutics Holdings, Inc.7月14日成交额为52.06万美元
Cero Therapeutics Holdings, Inc.盘中异动 急速下跌5.96%
市场透视 · 2025-03-03
Cero Therapeutics Holdings, Inc.盘中异动 急速下跌5.96%
Cero Therapeutics Holdings, Inc.盘中异动 临近午盘快速上涨5.12%
市场透视 · 2025-02-28
Cero Therapeutics Holdings, Inc.盘中异动 临近午盘快速上涨5.12%
Cero Therapeutics Holdings, Inc.盘中异动 股价大跌5.39%
市场透视 · 2025-02-25
Cero Therapeutics Holdings, Inc.盘中异动 股价大跌5.39%
Cero Therapeutics Holdings, Inc.盘中异动 股价大跌6.67%报1.67美元
市场透视 · 2025-02-24
Cero Therapeutics Holdings, Inc.盘中异动 股价大跌6.67%报1.67美元
Cero Therapeutics Holdings, Inc.盘中异动 急速下挫6.83%报1.91美元
市场透视 · 2025-02-21
Cero Therapeutics Holdings, Inc.盘中异动 急速下挫6.83%报1.91美元
Cero Therapeutics Holdings, Inc.盘中异动 早盘快速下挫6.80%报1.92美元
市场透视 · 2025-02-18
Cero Therapeutics Holdings, Inc.盘中异动 早盘快速下挫6.80%报1.92美元
Cero Therapeutics Holdings, Inc.盘中异动 快速下挫5.73%
市场透视 · 2025-02-11
Cero Therapeutics Holdings, Inc.盘中异动 快速下挫5.73%
Cero Therapeutics Holdings, Inc.盘中异动 早盘股价大跌5.70%报2.02美元
市场透视 · 2025-02-03
Cero Therapeutics Holdings, Inc.盘中异动 早盘股价大跌5.70%报2.02美元
Cero Therapeutics Holdings, Inc.盘中异动 早盘股价大涨5.03%
市场透视 · 2025-01-31
Cero Therapeutics Holdings, Inc.盘中异动 早盘股价大涨5.03%
Cero Therapeutics Holdings, Inc.盘中异动 大幅拉升5.66%
市场透视 · 2025-01-30
Cero Therapeutics Holdings, Inc.盘中异动 大幅拉升5.66%
Cero Therapeutics Holdings, Inc.盘中异动 急速跳水5.28%报1.77美元
市场透视 · 2025-01-28
Cero Therapeutics Holdings, Inc.盘中异动 急速跳水5.28%报1.77美元
Cero Therapeutics Holdings, Inc.盘中异动 早盘急速下跌8.79%报2.26美元
市场透视 · 2025-01-27
Cero Therapeutics Holdings, Inc.盘中异动 早盘急速下跌8.79%报2.26美元
Cero Therapeutics Holdings, Inc.盘中异动 急速跳水5.53%报2.22美元
市场透视 · 2025-01-24
Cero Therapeutics Holdings, Inc.盘中异动 急速跳水5.53%报2.22美元
Cero Therapeutics Holdings, Inc.盘中异动 快速下跌5.83%报2.10美元
市场透视 · 2025-01-23
Cero Therapeutics Holdings, Inc.盘中异动 快速下跌5.83%报2.10美元
Cero Therapeutics Holdings, Inc.盘中异动 早盘快速下跌11.69%报2.04美元
市场透视 · 2025-01-22
Cero Therapeutics Holdings, Inc.盘中异动 早盘快速下跌11.69%报2.04美元
加载更多
公司概况
公司名称：
CERo Therapeutics Holdings, Inc.
所属市场：
OTCQB
上市日期：
--
主营业务：
CERo Therapeutics Holdings, Inc.于2016年9月23日在特拉华州注册成立。CERo是一家创新的免疫治疗公司，致力于推动下一代工程T细胞疗法的开发，以治疗癌症。其专有的T细胞工程方法使其能够将先天性免疫和适应性免疫的某些理想特征整合到单一治疗结构中，旨在调动人体的全部免疫库以实现优化的癌症治疗。
发行价格：
--
{"stockData":{"symbol":"CERO","market":"US","secType":"STK","nameCN":"CERo Therapeutics Holdings, Inc.","latestPrice":0.0433,"timestamp":1768328220000,"preClose":0.045,"halted":0,"volume":529740,"delay":15,"floatShares":1762500,"shares":21702671,"eps":-98.705194,"marketStatus":"交易中","change":-0.0017,"latestTime":"01-13 13:17:00 EST 延时","open":0.0475,"high":0.0498,"low":0.0431,"amount":23948.71264872,"amplitude":0.148889,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-98.705194,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"exchange":"OTCQB","adjPreClose":0.045,"volumeRatio":1.409391},"requestUrl":"/m/hq/s/CERO","defaultTab":"news","newsList":[{"id":"1114257867","title":"Cero Therapeutics发布Cer-1236治疗AML的I期临床试验（CERTAINT-1）最新临床进展，重点披露关键安全性数据及骨髓增生异常综合征/AML患者实现无血小板输注间隔","url":"https://stock-news.laohu8.com/highlight/detail?id=1114257867","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114257867?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:10","pubTimestamp":1767795015,"startTime":"0","endTime":"0","summary":"Cero Therapeutics今日公布了其候选药物Cer-1236针对急性髓系白血病（AML）的I期临床试验（研究代号CERTAINT-1）的最新临床数据。此次更新重点展示了该疗法的关键安全性特征，并报告了一例同时患有骨髓增生异常综合征（MDS）和AML的患者，在接受治疗后观察到了无需输注血小板的间隔期。这一发现为评估Cer-1236的潜在临床益处提供了初步的积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"1183542713","title":"CERo Therapeutics Holdings, Inc.推进Cer-1236治疗AML的1期临床试验，初始剂量队列中第三名患者开始用药","url":"https://stock-news.laohu8.com/highlight/detail?id=1183542713","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183542713?lang=zh_cn&edition=full","pubTime":"2025-09-22 21:15","pubTimestamp":1758546914,"startTime":"0","endTime":"0","summary":"CERo Therapeutics Holdings, Inc.推进Cer-1236治疗AML的1期临床试验，初始剂量队列中第三名患者开始用药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CERO"],"gpt_icon":0},{"id":"1103282310","title":"CERo Therapeutics宣布在急性髓系白血病Cer-1236一期研究中进行剂量强化","url":"https://stock-news.laohu8.com/highlight/detail?id=1103282310","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103282310?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:46","pubTimestamp":1757335608,"startTime":"0","endTime":"0","summary":"CERo Therapeutics宣布在急性髓系白血病Cer-1236一期研究中进行剂量强化","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERO","BK4139"],"gpt_icon":0},{"id":"2551154391","title":"Cero Therapeutics Holdings, Inc.7月15日成交额为36.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551154391","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551154391?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:31","pubTimestamp":1752629477,"startTime":"0","endTime":"0","summary":"美东时间2025年7月15日，Cero Therapeutics Holdings, Inc.成交额为36.71万美元，成交额较昨日减少29.48%，当日成交量为4.41万股。Cero Therapeutics Holdings, Inc.于2025年7月15日跌3.34%，报8.38美元，该股过去5个交易日跌3.34%，年初至今跌93.02%，过去60日跌29.82%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-15|36.71万|-29.48%|4.41万|#|2025-07-14|52.06万|-45.39%|6.06万|#|2025-07-11|95.33万|-26.00%|10.91万|#|2025-07-10|128.82万|134.82%|14.47万|#|2025-07-09|54.86万|-65.90%|6.24万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093601a44d74ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716093601a44d74ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2551137630","title":"Cero Therapeutics Holdings, Inc.7月14日成交额为52.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551137630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551137630?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:31","pubTimestamp":1752543064,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，Cero Therapeutics Holdings, Inc.成交额为52.06万美元，成交额较昨日减少45.39%，当日成交量为6.06万股。Cero Therapeutics Holdings, Inc.于2025年7月14日跌0.57%，报8.67美元，该股过去5个交易日跌2.8%，年初至今跌92.78%，过去60日跌25.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-14|52.06万|-45.39%|6.06万|#|2025-07-11|95.33万|-26.00%|10.91万|#|2025-07-10|128.82万|134.82%|14.47万|#|2025-07-09|54.86万|-65.90%|6.24万|#|2025-07-08|160.86万|-29.11%|18.64万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715093526a44b04fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715093526a44b04fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","CERO","BK4139","BK4539"],"gpt_icon":0},{"id":"2516637837","title":"Cero Therapeutics Holdings, Inc.盘中异动 急速下跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637837?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:03","pubTimestamp":1741014204,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时03分，Cero Therapeutics Holdings, Inc.股票出现波动，股价大幅跳水5.96%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为985.13%、124.43%、98.85%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、48.34%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230324a25d49a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230324a25d49a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","BK4139","LENZ"],"gpt_icon":0},{"id":"2514387468","title":"Cero Therapeutics Holdings, Inc.盘中异动 临近午盘快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387468?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:31","pubTimestamp":1740673907,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时31分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速拉升5.12%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Alpha Tau Medical Ltd C/Wts 、Heron Therapeutics, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1663.56%、270.60%、113.10%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Quoin Pharmaceuticals Ltd、Pds Biotechnology Corporation，振幅分别为86.14%、47.79%、45.45%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228003147abdf8b8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228003147abdf8b8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","LENZ","BK4139"],"gpt_icon":0},{"id":"2514905390","title":"Cero Therapeutics Holdings, Inc.盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514905390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514905390?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:38","pubTimestamp":1740494281,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时38分，Cero Therapeutics Holdings, Inc.股票出现波动，股价急速下挫5.39%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为810.74%、577.02%、501.32%，振幅较大的相关个股有Organovo Holdings, Inc.、Gt Biopharma, Inc.、Moleculin Biotech, Inc.，振幅分别为100.27%、33.50%、20.56%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223801a25388be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223801a25388be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4139"],"gpt_icon":0},{"id":"2513208927","title":"Cero Therapeutics Holdings, Inc.盘中异动 股价大跌6.67%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513208927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513208927?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:37","pubTimestamp":1740407820,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时37分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速下跌6.67%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Aditxt, Inc.、Pepgen Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为43.84%、42.36%、24.48%，振幅较大的相关个股有Pepgen Inc.、Gossamer Bio, Inc.、Summit Therapeutics Inc.，振幅分别为85.40%、14.69%、14.51%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223700abdb0f32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223700abdb0f32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4139"],"gpt_icon":0},{"id":"2513311296","title":"Cero Therapeutics Holdings, Inc.盘中异动 急速下挫6.83%报1.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513311296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513311296?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148291,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Cero Therapeutics Holdings, Inc.股票出现波动，股价急速跳水6.83%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.、Nkgen Biotech, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、蓝鸟生物较为活跃，换手率分别为69.30%、61.25%、19.11%，振幅较大的相关个股有Osr Holdings, Inc.、蓝鸟生物、Aspire Biopharma Holdings, Inc.，振幅分别为14.17%、11.05%、10.55%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223131abd7af72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223131abd7af72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4139"],"gpt_icon":0},{"id":"2512165377","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘快速下挫6.80%报1.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165377?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:36","pubTimestamp":1739889366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时36分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速下跌6.80%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为286.19%、100.98%、75.77%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为34.04%、22.30%、20.73%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223607abd3b041&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223607abd3b041&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","LENZ","BK4139"],"gpt_icon":0},{"id":"2510335759","title":"Cero Therapeutics Holdings, Inc.盘中异动 快速下挫5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510335759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510335759?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:34","pubTimestamp":1739288071,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时34分，Cero Therapeutics Holdings, Inc.股票出现波动，股价快速下挫5.73%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.83%。其相关个股中，Ocean Biomedical, Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2658.55%、1035.78%、364.05%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211233431961f53ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211233431961f53ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","BK4139","LENZ"],"gpt_icon":0},{"id":"2508814175","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘股价大跌5.70%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508814175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508814175?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:36","pubTimestamp":1738593367,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时36分，Cero Therapeutics Holdings, Inc.股票出现波动，股价快速下挫5.70%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为355.09%、309.60%、145.69%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、27.90%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223607a2380ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223607a2380ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4139"],"gpt_icon":0},{"id":"2507969818","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507969818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507969818?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:47","pubTimestamp":1738334835,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时47分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速上涨5.03%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Nls Pharmaceutics Ltd.、Cyclerion Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为1584.83%、703.82%、85.55%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Nutriband Inc C/Wts ，振幅分别为63.20%、43.70%、42.27%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131224715a2354549&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131224715a2354549&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4139"],"gpt_icon":0},{"id":"2507621844","title":"Cero Therapeutics Holdings, Inc.盘中异动 大幅拉升5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507621844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507621844?lang=zh_cn&edition=full","pubTime":"2025-01-30 22:34","pubTimestamp":1738247642,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时34分，Cero Therapeutics Holdings, Inc.股票出现异动，股价快速上涨5.66%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为651.32%、126.50%、106.30%，振幅较大的相关个股有Kazia Therapeutics Limited、Tectonic Therapeutic, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为23.91%、21.38%、21.31%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223402abbd4cd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130223402abbd4cd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","BK4139","LENZ"],"gpt_icon":0},{"id":"2506511038","title":"Cero Therapeutics Holdings, Inc.盘中异动 急速跳水5.28%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506511038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506511038?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:32","pubTimestamp":1738074768,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时32分，Cero Therapeutics Holdings, Inc.股票出现波动，股价快速下跌5.28%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1368.56%、601.84%、220.18%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Allarity Therapeutics, Inc.、Atyr Pharma, Inc.，振幅分别为113.03%、103.25%、102.25%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822324998756bab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822324998756bab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CERO"],"gpt_icon":0},{"id":"2506308218","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘急速下跌8.79%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506308218?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:31","pubTimestamp":1737988278,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时31分，Cero Therapeutics Holdings, Inc.股票出现波动，股价快速下跌8.79%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Akero Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、89Bio, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为718.34%、39.56%、34.98%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Akero Therapeutics, Inc.、Biocardia, Inc.，振幅分别为11.62%、11.19%、10.50%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223118a2316a8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223118a2316a8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4139"],"gpt_icon":0},{"id":"2505866413","title":"Cero Therapeutics Holdings, Inc.盘中异动 急速跳水5.53%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505866413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505866413?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:33","pubTimestamp":1737729200,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时33分，Cero Therapeutics Holdings, Inc.股票出现波动，股价大幅下跌5.53%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Pmgc Holdings Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为2038.32%、1201.16%、841.85%，振幅较大的相关个股有Pmgc Holdings Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As，振幅分别为26.26%、23.15%、21.70%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223321abb74ee5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223321abb74ee5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CERO","BK4139"],"gpt_icon":0},{"id":"2505112800","title":"Cero Therapeutics Holdings, Inc.盘中异动 快速下跌5.83%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505112800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505112800?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642676,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Cero Therapeutics Holdings, Inc.股票出现波动，股价大幅下挫5.83%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Hepion Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Vigil Neuroscience, Inc.较为活跃，换手率分别为1752.41%、462.63%、36.38%，振幅较大的相关个股有Exicure, Inc.、Channel Therapeutics Corporation、Hepion Pharmaceuticals, Inc.，振幅分别为13.69%、10.74%、10.52%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501232231169870b8e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501232231169870b8e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CERO"],"gpt_icon":0},{"id":"2505072667","title":"Cero Therapeutics Holdings, Inc.盘中异动 早盘快速下跌11.69%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505072667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505072667?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:31","pubTimestamp":1737556269,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时31分，Cero Therapeutics Holdings, Inc.股票出现异动，股价急速下挫11.69%。Cero Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Immunoprecise Antibodies Ltd.、Nutriband Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为429.53%、86.53%、50.31%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Cero Therapeutics Holdings, Inc.、Cocrystal Pharma, Inc.，振幅分别为20.57%、11.26%、8.65%。Cero Therapeutics Holdings, Inc.公司简介：CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司，致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223110960cfef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223110960cfef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERO","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cero.bio","description":"CERo Therapeutics Holdings, Inc.于2016年9月23日在特拉华州注册成立。CERo是一家创新的免疫治疗公司，致力于推动下一代工程T细胞疗法的开发，以治疗癌症。其专有的T细胞工程方法使其能够将先天性免疫和适应性免疫的某些理想特征整合到单一治疗结构中，旨在调动人体的全部免疫库以实现优化的癌症治疗。","exchange":"OTCQB","name":"CERo Therapeutics Holdings, Inc.","nameEN":"CERo Therapeutics Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CERo Therapeutics Holdings, Inc.(CERO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CERo Therapeutics Holdings, Inc.(CERO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CERo Therapeutics Holdings, Inc.,CERO,CERo Therapeutics Holdings, Inc.股票,CERo Therapeutics Holdings, Inc.股票老虎,CERo Therapeutics Holdings, Inc.股票老虎国际,CERo Therapeutics Holdings, Inc.行情,CERo Therapeutics Holdings, Inc.股票行情,CERo Therapeutics Holdings, Inc.股价,CERo Therapeutics Holdings, Inc.股市,CERo Therapeutics Holdings, Inc.股票价格,CERo Therapeutics Holdings, Inc.股票交易,CERo Therapeutics Holdings, Inc.股票购买,CERo Therapeutics Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CERo Therapeutics Holdings, Inc.(CERO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CERo Therapeutics Holdings, Inc.(CERO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}